TTI’s thought leaders have over more than 30 years of experience in generating and translating evidence into market access strategies that fuel commercial success.

Our expertise and service offerings include:

Access & Strategy

  • Strategic market access roadmaps
  • Coverage, coding and reimbursement assessment and strategy
  • Policy research, analysis and strategy
  • Baseline research and monitoring of HTAs, clinical trials, country requirements, and coverage policies
  • RWE/HEOR strategy and gap analysis
  • Payor, provider and patient qualitative interviews research/ surveys
  • Policy research, analysis and strategy
  • Coverage, coding and reimbursement assessment and strategy
  • Competitive analysis
  • Health economic and financial models
  • Claims analysis and payment modeling
  • Pricing strategies

Evidence Generation

  • Health economic modeling (Cost-effectiveness, ROI, budgetary impact)
  • Literature review
  • Meta-analysis
  • Incidence, prevalence and burden of illness
  • Prospective observational clinical-economic studies
  • Retrospective EMR analyses
  • Claims database analyses
  • Protocol review / modification
  • Incorporation of economic and patient-reported PRO endpoints into Phase II-IV protocols
  • PRO instrument selection and adaptation
  • PRO instrument development and validation
  • Post-market registry study design

 

 

Value Communication

  • Publications and publication planning
  • HTA planning and submissions
  • Payor dossier development
  • Value toolkits and presentations, including custom interactive tools
  • Payor liaison, sales representative, and clinical KOL training on value presentation
  • Investor-focused PPTs
  • Value-based sales tools
  • White papers
  • Content targeted to key payor and purchaser audiences
  • Interactive budget impact models